Financials

News Discussions Technicals Seasonals

4598 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Delta-Fly Pharma, Inc. engages in the manufacturing, sale, research and development of pharmaceutical products for cancer treatment. It also provides module technology for motorcars, telepone, oncology drug discovery, treating metastatic ovarian cancer with DFP-10825, liposome-conjugated RNAi molecule and others. The company was founded by Kiyoshi Eshima on December 6, 2010 and is headquartered in Tokushima, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4598 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company